Mutations of other genes in the Fanconi anemia pathway also confer increased ovarian cancer risk, including PALB2 [12,13]; ATM [14]; RAD51C/D [15,16,17]; and BRIP1 [18,19]. Here, PALB2 is linked to ovarian cancer.